May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 28, 2025

Statins Recommended for HIV Patients at Risk for Heart Disease

Guidelines from the Department of Health and Human Services recommend statins as primary prevention for people with HIV aged 40 to 75 years who have a 10-year ASCVD risk of 5% or higher.

Conexiant

May 27, 2025

Minimally Invasive Option for Severe Mitral Annular Calcification

The FDA has approved Abbott’s Tendyne system, the first transcatheter mitral valve replacement for patients with severe mitral annular calcification who are ineligible for open-heart surgery.

Conexiant

May 23, 2025

BMI, Glucose, Blood Pressure Linked to Multimorbidity

A 30-year cohort study found that life-course factors—including BMI, blood pressure, and glucose—significantly influence chronic disease accumulation, but much of the risk remains unexplained.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 19, 2025

No-Touch Technique May Improve CABG Graft Outcomes

A large study of 2,655 CABG patients found that using the no-touch technique to harvest vein grafts significantly reduced blockage, heart attacks, and repeat procedures over three years.

Conexiant

May 15, 2025

Men With Broken Heart Syndrome Have Twice the Mortality Risk: Study

A large U.S. study of nearly 200,000 Takotsubo cardiomyopathy cases found persistently high mortality—especially among men—despite rising incidence and increased recognition from 2016 to 2020.

Conexiant

May 13, 2025

Arterial Plaque Analysis Links Micronanoplastics to Stroke History

Study detects up to 50-fold more microplastics in plaques compared to healthy artery walls

The Analytical Scientist

May 13, 2025

Tirzepatide Reduces Muscle Fat in Diabetes: Study 

A 52-week MRI analysis found that tirzepatide reduced muscle fat infiltration more than insulin degludec in adults with type 2 diabetes, with muscle volume changes aligning with expected weight loss patterns.

Conexiant